Nationwide recall issued for this thyroid medication. See products - USA Today

What the report says

USA Today reported that Major Rugby has issued a nationwide recall of several levothyroxine sodium tablet products, a prescription thyroid medication. The recall was described in a letter the company sent to retailers earlier in July, with USA Today’s article published July 27, 2026, and updated July 28. The affected tablets were distributed across the United States beginning in January 2025 and were sold under the Major and Cardinal brand names.

According to USA Today, the recall covers 12 product packages, including 100-tablet boxes made up of 10 blister packs and smaller 10-tablet packs. The listed strengths include 25 mcg, 50 mcg, 75 mcg, 88 mcg, 112 mcg, 125 mcg and 150 mcg, with affected lot numbers and expiration dates ranging from July 2026 through January 2027. The company’s letter and an FDA report identified the issue as subpotency, meaning the tablets may contain less active medication than intended.

Major Rugby said in its retailer letter that use of the recalled medicine is not expected to cause adverse health effects, USA Today reported. Even so, consumers were advised to return affected products to the place where they bought them and to speak with a doctor or physician if they have the recalled medication.

Levothyroxine is commonly prescribed for hypothyroidism and may also be used for enlarged thyroid glands and certain thyroid cancers, according to Mayo Clinic information cited by USA Today. Because thyroid hormone dosing can be clinically important, the recall may matter most for patients who depend on consistent medication levels and need guidance on replacement supplies.